IOC.NS Indian Oil Corporation Limited
INR·Price 143.43·Mkt cap 2.03TComputed from the latest reported financials and the current market price.
Who's the real player?
A genuine play on this theme — most of its business sits right here.
Is the business healthy?
Healthy business: it turns profit into real cash and earns solid returns on capital.
- Strong cash flow quality
- High FCF conversion ratio
- Low accruals
- Strong growth quality
- Positive forensic indicators
Are the smart people buying?
No ownership-change data for this stock. Conviction is judged from capex and buyback signals alone.
- High promoter/insider ownership
- Moderate institutional ownership
What is management saying?
No earnings-call transcript or filings found for this stock.
Is the price right?
Intrinsic value 448.04 vs price 143.43 — screens cheap on a cash-flow DCF (212.4% to intrinsic). The base DCF growth assumption of 8% is not believable given the negative reverse-DCF implied growth, which suggests that current pricing may be overly optimistic.
| Intrinsic / share | 448.04 |
| Price | 143.43 |
| Upside to intrinsic | 212.4% |
| Reverse-DCF implied g | -3.6% |
Base FCF 408.75B · growth 8.0% · discount 12.0% · terminal 5.0%.
Sensitivity — intrinsic value / share
Each cell is the intrinsic value at that growth (across →) and discount rate (down ↓). Center ★ is the base case. Cells green = above price (cheap), red = below (expensive).
| Growth rate → | |||||
|---|---|---|---|---|---|
| Disc ↓ ╲ g | 4% | 6% | 8% | 10% | 12% |
| 10% | 470.25 | 565.09 | 675.94 | 805.27 | 955.87 |
| 11% | 377.88 | 454.05 | 542.84 | 646.17 | 766.23 |
| 12% | 311.84 | 374.82 | ★ 448.04 | 533.05 | 631.6 |
| 13% | 262.24 | 315.46 | 377.16 | 448.62 | 531.29 |
| 14% | 223.62 | 269.34 | 322.21 | 383.31 | 453.82 |
Through the masters' eyes
Each investor's numeric rules, checked against this stock's metrics: exact math, no guesswork. Tap one to see which rules pass, fail, and what to judge yourself.
Financial statements (INR)
↗ sourceCash-flow lines highlighted — we trust cash over reported profit.
| Line | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | 7.84T | 7.58T | 7.73T | 8.28T | — |
| Operating income | 597.77B | 194.30B | 613.45B | 259.14B | — |
| EBITDA | 842.00B | 431.00B | 807.38B | 348.66B | — |
| Net income | 420.96B | 135.98B | 417.30B | 97.92B | — |
| Operating cash flow | 761.42B | 344.52B | 711.46B | 296.44B | — |
| Capex | -283.63B | -349.67B | -371.75B | -328.50B | — |
| Free cash flow | 477.79B | -5.15B | 339.71B | -32.06B | — |
| Total assets | 5.29T | 5.07T | 4.82T | 4.42T | — |
| Total equity | 2.20T | 1.86T | 1.83T | 1.40T | — |
| Total debt | 1.32T | 1.52T | 1.33T | 1.49T | — |
| Cash & equivalents | 18.33B | 6.73B | 12.47B | 9.96B | — |